Evidence map›Paper›PMID 39330100›Full record

ArticleEntropy (Basel, Switzerland)2024

Optimizing Prognostic Predictions in Liver Cancer with Machine Learning and Survival Analysis.

Kaida Cai, Wenzhi Fu, Zhengyan Wang, Xiaofang Yang, Hanwen Liu, Ziyang Ji

Abstract read
In one paragraph

Article in Entropy (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kaida CaiDepartment of Epidemiology and Biostatistics, School of Public Health, Southeast University, Nanjing 210009, China.ORCID 0000-0003-2262-3869
Wenzhi FuDepartment of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.
Zhengyan WangDepartment of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.
Xiaofang YangDepartment of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.
Hanwen LiuDepartment of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.
Ziyang JiDepartment of Statistics and Actuarial Science, School of Mathematics, Southeast University, Nanjing 211189, China.

Funding

Fundamental Research Funds for the Central Universities 2242023R40055National Natural Science Foundation of China 12301334Natural Science Foundation of Jiangsu Province BK20230804
6 · The paper itself

Abstract

This study harnesses RNA sequencing data from the Cancer Genome Atlas to unearth pivotal genetic markers linked to the progression of liver hepatocellular carcinoma (LIHC), a major contributor to cancer-related deaths worldwide, characterized by a dire prognosis and limited treatment avenues. We employ advanced feature selection techniques, including sure independence screening (SIS) combined with the least absolute shrinkage and selection operator (Lasso), smoothly clipped absolute deviation (SCAD), information gain (IG), and permutation variable importance (VIMP) methods, to effectively navigate the challenges posed by ultra-high-dimensional data. Through these methods, we identify critical genes like MED8 as significant markers for LIHC. These markers are further analyzed using advanced survival analysis models, including the Cox proportional hazards model, survival tree, and random survival forests. Our findings reveal that SIS-Lasso demonstrates strong predictive accuracy, particularly in combination with the Cox proportional hazards model. However, when coupled with the random survival forests method, the SIS-VIMP approach achieves the highest overall performance. This comprehensive approach not only enhances the prediction of LIHC outcomes but also provides valuable insights into the genetic mechanisms underlying the disease, thereby paving the way for personalized treatment strategies and advancing the field of cancer genomics.

Indexed as

feature selectioninformation gainliver hepatocellular carcinomamachine learningsurvival analysis

Identifiers

PMID39330100
PMCPMC11431161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.